Evelyn Partners’s Adient ADNT Stock Holding History

Evelyn Partners’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.27K	Hold	313	–	–	﹤0.01%	601
2026 Q2	$5.75K	Buy	+313	New	+$6.69K	﹤0.01%	503

Other funds holding ADNT

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.9B AUM 29.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

HITE Hedge Asset Management Braintree, Massachusetts $1.82B AUM 7.29% 1-Year Est. Return

Evelyn Partners's ADNT Position: Q3 2026 in Review

Evelyn Partners held its Adient (ADNT) position steady in Q3 2026 at 313 shares worth $5.27K. The position accounts for ﹤0.01% of the portfolio, ranked #601.

Evelyn Partners first reported a position in ADNT in Q2 2026 and has held it in 2 quarters since. The position peaked at $5.75K in Q2 2026. 237 funds tracked by Wall St. Rank hold ADNT as of Q3 2026.

Evelyn Partners held 313 shares of Adient worth $5.27K as of Q3 2026.
Evelyn Partners left its Adient share count unchanged in Q3 2026.
Adient made up ﹤0.01% of Evelyn Partners's portfolio in Q3 2026, its #601 holding.
Evelyn Partners first reported a position in Adient in Q2 2026 and has held it in 2 quarters since.
Evelyn Partners's Adient position peaked at $5.75K in Q2 2026.
237 funds tracked by Wall St. Rank held Adient as of Q3 2026.

Based on Evelyn Partners's 13F filing for Q3 2026, filed 10 Nov 2026.